
Genetix Announces Transformation Into a Profitable, High-Growth Commercial Leader in Rare Disease Genetic Medicine
Genetix Biotherapeutics Reports Strong 2026 Commercial Growth, Achieves Profitability and Targets Multibillion-Dollar Expansion Genetix Biotherapeutics Inc., a commercial leader in genetic medicines for rare diseases with a primary focus on…














